2017 April AVATAR Newsletter
18 April 2017

The 2017 April AVATAR Newsletter is out. Please, click this link to read it.

You can have a look at our previous newsletters on the website at http://www.avatargroup.org.au/newsletters.html

Draft genome sequence of Roseomonas mucosa strain AU37, isolated from a peripheral intravenous catheter
13 April 2017
Received 3 February 2017 Accepted 7 February 2017 Published 13 April 2017 Citation Abu Choudhury M, Wailan AM,
Sidjabat HE, Zhang L, Marsh N, Rickard CM,
Davies MR, McMillan DJ. ...
Report from AVATAR state of the art in vascular access management seminar
7 April 2017
On March 6 just under 100 dedicated clinicians joined us for the inaugural AVATAR State of the Art in Vascular Access Management seminar, held at Rydges Parramatta.  They were a mixed bunch ...
How to assess a peripheral intravenous (IV) cannula
5 April 2017
Most patients need at least one peripheral intravenous catheter (PIVC) during their hospital stay for IV fluids and medications, blood products or nutrition. PIVC complications are common, but t...
Scoping the evidence for CVADs
3 April 2017
Central venous access devices (CVADs) provide access to the greater vascular system to administer therapy that is contraindicated to be given peripherally, for longer term treatment, and for ven...
Is it time for a protocol for long-term central venous access? A caregiver's perspective
31 March 2017
Note: This blog presents the personal opinion and experience of the author, and the practices described here are not an endorsement by the AVATAR Group.   Being the caregiver of a child ...

Address

Griffith University
Nathan
Queensland
Australia 4111